| 1 |
35267550 | Hairy Cell Leukemia Patients Have a Normal Life Expectancy-A 35-Year Single-Center Experience and Comparison with the General Population. | 2022 Feb 28 |
1 |
| 2 |
35467089 | The influence of venetoclax, used alone or in combination with cladribine (2-CdA), on CLL cells apoptosis in vitro: Preliminary results. | 2022 Apr 25 |
1 |
| 3 |
33093752 | The Efficacy of Cladribine (2-CdA) in Advanced Systemic Mastocytosis. | 2020 Oct |
1 |
| 4 |
26580149 | Long-term safety and activity of cladribine in patients with extranodal B-cell marginal zone lymphoma of the mucosa-associated lymphoid tissue (MALT) lymphoma. | 2017 Jun |
1 |
| 5 |
21182289 | Comprehensive proteomic analysis of the effects of purine analogs on human Raji B-cell lymphoma. | 2011 Mar 4 |
1 |
| 6 |
21679466 | Therapeutic potential of cladribine in combination with STAT3 inhibitor against multiple myeloma. | 2011 Jun 16 |
1 |
| 7 |
22084681 | Cladribine and Fludarabine Nucleoside Change the Levels of CD Antigens on B-Lymphoproliferative Disorders. | 2010 |
1 |
| 8 |
18076637 | Cladribine combined with high doses of arabinoside cytosine, mitoxantrone, and G-CSF (CLAG-M) is a highly effective salvage regimen in patients with refractory and relapsed acute myeloid leukemia of the poor risk: a final report of the Polish Adult Leukemia Group. | 2008 Feb |
1 |
| 9 |
16990114 | Hairy cell leukemia: towards a curative strategy. | 2006 Oct |
1 |
| 10 |
17107901 | 2-CdA in the treatment of hairy cell leukemia: a review of long-term follow-up. | 2006 Nov |
1 |
| 11 |
15761021 | Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA): long-term follow-up of the Northwestern University experience. | 2005 Jul 1 |
1 |
| 12 |
15813915 | In vitro cytotoxic effect of proteasome inhibitor bortezomib in combination with purine nucleoside analogues on chronic lymphocytic leukaemia cells. | 2005 May |
1 |
| 13 |
15075093 | Occurrence of a myelodysplastic syndrome (MDS) during first-line 2-chloro-deoxyadenosine (2-CDA) treatment of a low-grade gastrointestinal MALT lymphoma. Case report and review of the literature. | 2004 Apr |
1 |
| 14 |
15324388 | Cutaneous adverse reaction to 2-chlorodeoxyadenosine with histological flame figures in patients with chronic lymphocytic leukaemia. | 2004 Sep |
1 |
| 15 |
15332715 | Role of low-dose 2-CdA in refractory or resistant lymphoplasmocytic lymphoma. | 2004 Aug |
1 |
| 16 |
12473386 | Influence of p53 and p21(WAF1) expression on sensitivity of cancer cells to cladribine. | 2003 Jan 1 |
1 |
| 17 |
12610885 | [Cladribine]. | 2003 Feb |
1 |
| 18 |
12670465 | Splenectomy and treatments of historical interest. | 2003 Mar |
1 |
| 19 |
12691159 | In AML cell lines Ara-C combined with purine analogues is able to exert synergistic as well as antagonistic effects on proliferation, apoptosis and disruption of mitochondrial membrane potential. | 2003 Jan |
1 |
| 20 |
12930387 | Cutaneous reactions in hairy cell leukaemia treated with 2-chlorodeoxyadenosine and allopurinol. | 2003 Sep |
1 |
| 21 |
17472258 | Treatment of cutaneous T-cell lymphomas with purine analogues (fludarabine and 2-chlorodeoxyadenosine). | 2003 Jul-Sep |
2 |
| 22 |
11891804 | Treatment of children with Langerhans cell histiocytosis with 2-chlorodeoxyadenosine. | 2002 Mar |
1 |
| 23 |
11948108 | Therapeutic potential of a reduced-intensity preparative regimen for allogeneic transplantation with cladribine, busulfan, and antithymocyte globulin against advanced/refractory acute leukemia/lymphoma. | 2002 Apr |
1 |
| 24 |
11168501 | Unexpectedly high incidence of hypoplastic/aplastic foci in bone marrow biopsies of hairy cell leukemia patients in remission following 2-chlorodeoxyadenosine therapy. | 2001 Jan |
1 |
| 25 |
11378572 | Does intensive treatment with high dose chlorambucil and prednisone as first line and cladribine as second line influence the survival of the patients with chronic lymphocytic leukemia? | 2001 May |
1 |
| 26 |
11426528 | Cladribine in the treatment of chronic lymphocytic leukemia. | 2001 Feb |
1 |
| 27 |
10778958 | Sequential treatment of a resistant chronic lymphocytic leukemia patient with bryostatin 1 followed by 2-chlorodeoxyadenosine: case report. | 2000 Apr |
1 |
| 28 |
10996206 | Phase II trial of 2-chlorodeoxyadenosine in patients with relapsed/refractory acute myeloid leukemia: a study of the Eastern Cooperative Oncology Group (ECOG), E5995. | 2000 Oct |
1 |
| 29 |
10319384 | Treatment of hairy-cell leukemia: current views. | 1999 Apr |
1 |
| 30 |
10414453 | Effect of a 2-hour infusion of 2-chlorodeoxyadenosine in the treatment of refractory or previously untreated Waldenström's macroglobulinemia. | 1999 Jul |
1 |
| 31 |
10587972 | Graft-vs.-malignancy with allogeneic blood stem cell transplantation: a potential primary treatment modality. | 1999 |
1 |
| 32 |
10677889 | Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine). | 1999 Dec 23 |
1 |
| 33 |
9486920 | 2-Chlorodeoxyadenosine with or without daunorubicin in relapsed or refractory acute myeloid leukemia. | 1998 Jan |
1 |
| 34 |
9558908 | Five day intermittent vs seven day continuous 2-chlorodeoxyadenosine infusion for the treatment of hairy cell leukemia. A study by Italian Group for the Hairy Cell Leukemia. | 1998 Feb |
1 |
| 35 |
9672772 | New prospects in the treatment of indolent lymphomas with purine analogues. | 1998 Jul |
1 |
| 36 |
10021885 | [Hairy cell leukemia--a potentially curable malignancy. Selected aspects of purine analog therapy]. | 1998 |
1 |
| 37 |
9020373 | 2-Chlorodeoxyadenosine in the treatment of relapsed/refractory chronic lymphoproliferative disorders. | 1997 Jan |
1 |
| 38 |
9178834 | Purine analogs in the treatment of chronic lymphocytic leukemia. | 1997 Apr |
1 |
| 39 |
9385350 | The safety profile of low-dose cladribine in refractory rheumatoid arthritis. A pilot trial. | 1997 |
1 |
| 40 |
9570679 | Hairy cell leukemia and allied chronic lymphoid leukemias: current knowledge and new therapeutic options. | 1997 Dec |
1 |
| 41 |
8698907 | Treatment of scleromyxedema with 2-chlorodeoxyadenosine. | 1996 Aug |
1 |
| 42 |
8774616 | 2-Chlorodeoxyadenosine treatment in non-Hodgkin's lymphoma and B-cell chronic lymphocytic leukemia resistant to conventional chemotherapy: results of a multicentric experience. International Society for Chemo-Immunotherapy. | 1996 Aug |
1 |
| 43 |
8891014 | Cutaneous reactions after treatment with 2-chlorodeoxyadenosine. | 1996 Sep |
1 |
| 44 |
8999463 | [Clinical pharmacology of 2-chlorodeoxyadenosine (Cladribine)]. | 1996 |
1 |
| 45 |
7669706 | Purine analogs in the treatment of low-grade lymphomas and chronic lymphocytic leukemias. | 1995 May |
1 |
| 46 |
7697598 | The simultaneous occurrence of variant hairy cell leukemia and chronic-phase chronic myelogenous leukemia. A case report. | 1995 Apr 15 |
1 |
| 47 |
7707127 | Cladribine in the treatment of relapsed or refractory chronic lymphocytic leukemia. | 1995 Apr |
1 |
| 48 |
7884417 | 2-Chlorodeoxyadenosine activity in patients with untreated chronic lymphocytic leukemia. | 1995 Mar |
1 |
| 49 |
8555073 | 2-Chloro-deoxyadenosine therapy for giant lymph node hyperplasia. | 1995 Nov |
1 |
| 50 |
8617573 | Investigation of the comparative effects of 2-chlorodeoxyadenosine on tumor colony forming units in vitro. | 1995 |
1 |